Investigating How to Manipulate Metabolic Reprogramming for IPF Treatment

Time: 5:00 pm
day: Day One


  • An overview of the metabolic context of IPF
  • Comprehensively analyzing the relationship between IPF patient phenotype and underlying metabolic disease
  • Hearing how to address factors such as obesity, glucose intolerance, insulin resistance and diabetes in a pre-clinical setting for IPF drug development